Loading contract…
BETAThis is a new independent transparency project, not an official government website. The data is sourced from public registers and may contain errors, so always verify against the official source. If you find a problem, please report it here.
NHS Framework for the supply of drugs licensed specifically to target epidermal growth factor receptor (EGFR)-expressing, RAS wild-type metastatic colorectal cancer
| Supplier | Identifier | Award Value | Cross-References |
|---|---|---|---|
| Amgen Ltd | 02354269 | ~£75,000,000 estimated from lot values | - |
| Merck Serono Limited | 00990823 | ~£75,000,000 estimated from lot values | MP LINK Munira Wilson— Employment and earnings |
Government spending data: These suppliers have received £8,545,005 in 821 payments (over £25k) from Guy's and St Thomas' NHS FT, University Hospitals Bristol and Weston NHS FT, Manchester University NHS Foundation Trust, Department of Health and Social Care, Maidstone and Tunbridge Wells NHS Trust and 7 more public bodies (2019-04-17 to 2026-03-26).